Inactive Instrument
Global Blood Therapeutics, Inc. Stock
Stocks
GBT
US37890U1088
Biotechnology & Medical Research
| 1 day | +0.01% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/10/22 | Issuer sale | Chief Financial Officer | 448,218 | 0.6643% | ||
| 5/10/22 | Issuer sale | Director | 29,709 | 0.0440% | ||
| 5/10/22 | Issuer sale | Director | 62,923 | 0.0933% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +0.56% | - | - | 4.62B | |
| +0.04% | +3.19% | +7.21% | +30.16% | 47.56B | |
| -0.83% | -0.36% | +43.66% | +34.77% | 44.09B | |
| -0.84% | +4.86% | +10.92% | +91.52% | 41.5B | |
| -1.10% | -2.64% | +331.49% | +535.80% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| -2.07% | +0.12% | +24.39% | +154.30% | 17.23B | |
| +1.39% | +0.36% | +24.65% | +40.96% | 15.06B | |
| -6.08% | -9.92% | - | - | 14.65B | |
| -0.78% | +9.46% | -8.96% | - | 13.82B | |
| Average | -1.15% | +0.69% | +54.31% | +133.36% | 29.39B | |
| Weighted average by Cap. | -0.95% | +0.96% | +67.95% | +141.15% |
Employees
457
